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“How does T cell receptor signaling begin?” Answering this question requires an under-
standing of how the parts of the molecular machinery that mediates this process fit and
work together. Ultimately this molecular architecture must (i) trigger the relay of informa-
tion from the TCR-pMHC interface to the signaling substrates of the CD3 molecules and
(ii) bring the kinases that modify these substrates in close proximity to interact, initiate,
and sustain signaling. In this contribution we will discuss advances of the last decade that
have increased our understanding of the complex machinery and interactions that underlie
this type of signaling.
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INTRODUCTION
In our experience, immunologists who have not directly worked
on this problem are often shocked to learn that, 25+ years after its
initial discovery and characterization, we consider the question of
“How does T cell receptor signaling begin?”to remain unanswered.
No doubt, a great deal of progress has been made. For example,
it is well established that TCR signaling is initiated when the TCR
binds composite surfaces of peptides embedded in major histo-
compatibility complex (pMHC) molecules. It is also accepted that
the Src kinase Lck, which is associated with CD4 or CD8, phos-
phorylates the immunoreceptor tyrosine-based activation motifs
(ITAMs) of the TCR-associated CD3γε, δε, and ζζ signaling dim-
mers when both the TCR and CD4 or CD8 bind class II or class I
pMHC, respectively. Modification of the ITAMs then connects the
TCR-CD3 complex to the intracellular signaling apparatus. Addi-
tionally, a great deal is now known about the ensuing signaling
cascade to the nucleus. Thus, for most, this extensive understand-
ing of the “business ends” of the TCR-CD3 complex represents
a satisfactory explanation for how TCR signaling begins. It also
highlights the significant advances made by the field in defin-
ing the rules that govern TCR-pMHC interactions and identifying
the major players and sequence of events that transmit informa-
tion from the ITAMs to the nucleus (Rudolph et al., 2006; Garcia
et al., 2009; Smith-Garvin et al., 2009). Yet, there remains a lack of
Abbreviations: ECD, extracellular domain; ICD, intracellular domain; ITAM,
immune receptor tyrosine-based activation motifs; pMHC, peptide-major histo-
compatibility complex; TCR, T cell receptor; TM, transmembrane domain.
clarity about the mechanism(s) that trigger the initial transmission
of information from the TCR-pMHC interface to the ITAMS. Our
limited understanding of these processes reflects the complexity of
the molecular machinery under discussion as well as the challenges
researchers have faced when attempting to deconstruct and under-
stand the processes of how TCR signaling begins. Nevertheless, the
significance of the problem invites and requires persistence.
TCR triggering remains one of the most important basic
research problems facing the field of immunology. The significance
of this question is rooted in the fact that properly functioning
T cells are essential for vertebrate immunity–without them you
cannot survive for very long, even in the relatively hygienic devel-
oped world (Haase, 1999; Morgan et al., 2011). But, merely having
T cells is insufficient to ensure survival in an environment full
of pathogens. If they cannot properly relay information about
the quantity and quality of pMHC on the surfaces of antigen-
presenting cells (APCs) to their intracellular signaling apparatus,
and then on to the nucleus, they will not be able to make the appro-
priate cell fate decisions regarding: if a precursor T cell develops
to join the mature T cell repertoire (Starr et al., 2003); if a T cell
becomes activated upon antigen encounter (Corse et al., 2010,
2011); the number of daughter cells made by any single T cell
upon clonal expansion (Malherbe et al., 2008; Zehn et al., 2009;
Corse et al., 2010, 2011); the phenotype to which those daughter
cells differentiate upon activation; and the execution of effector
functions upon repeated antigen encounter (Constant and Bot-
tomly, 1997; Fazilleau et al., 2009; McHeyzer-Williams et al., 2009;
Gottschalk et al., 2010). Thus, the TCR-CD3 complex represents
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the chief molecular checkpoint for T cell development, activa-
tion, and function. Defects in these fate decisions can result in
immune-compromised individuals who are likely to suffer from
complex diseases associated with immune-disregulation (Ohashi,
2002; Holst et al., 2008; Vercelli, 2008).
The central role of the TCR-CD3 complex in immunity and
human health is a prime motivator for understanding the molecu-
lar mechanisms by which it functions. Such knowledge will inform
practical efforts aimed at promoting T cell responses to vaccines,
tumor, or pathogen. It will also guide efforts to attenuate responses
to auto-antigens or beneficial commensal organisms. Indeed, the
TCR-CD3 complex has been and continues to be targeted for
the development of immune-modulating reagents. Modified anti-
CD3ε antibodies are used to attenuate graft rejection, and such
reagents hold potential for treating autoimmunity (Chatenoud,
2005; Chatenoud and Bluestone, 2007; You and Chatenoud, 2010).
But, the mechanism of action of these antibodies is poorly under-
stood. The complex is also the primary focus of gene therapy
strategies aimed at reprograming the specificity of T cells (e.g., to
target tumor cells; Rosenberg et al., 2008). However, the nature of
TCR-CD3 complex assembly does not favor the incorporation of
exogenous TCRs into complexes on cells expressing endogenous
receptors. A better understanding of the assembly and function
of the complex is important for guiding gene therapy (Cohen
et al., 2006). Undoubtedly, more insights into how the parts of
this molecular machine fit and work together will inform the next
generation of a variety of immunotherapeutic strategies.
Increased insights into the TCR-CD3 complex are also likely
to have a broader impact on our basic and practical knowledge.
This complex represents one of the most complicated and sensitive
molecular machines identified to date (Kuhns et al., 2006; Davis
et al., 2007). Nature often employs similar strategies to accom-
plish related tasks; thus, elucidating the mechanisms by which the
TCR-CD3 complex functions is likely to provide valuable insights
into the functions of related activating immune receptor com-
plexes (e.g., NK or Fc receptors) as well as other multi-molecular
signaling complexes (Call and Wucherpfennig, 2007).
THE HEART OF THE MATTER
We will discuss the question of how TCR signaling begins from the
standpoint of what we consider to be the minimal essential molec-
ular components needed for robust TCR signaling: the TCR-CD3
complex subunits, the CD4, and CD8 co-receptors, and agonist
pMHC.
There are two fundamental requirements that must be met in
order for modular biosensors to transduce a signal across a mem-
brane. The first is that signaling substrates inside the cell must be
made accessible to modification by signaling enzymes upon lig-
and engagement if they are not accessible by default. The second
is that these signaling substrates must be brought into the appro-
priate spatial relationship with the enzymes that modify them in
order to initiate signaling upon ligand engagement. At present,
we do not fully understand (i) how TCR engagement triggers the
relay of information from the TCR-pMHC interface to the CD3
ITAMs to make them accessible for phosphorylation by the Src
kinase Lck, or (ii) how the ITAMs and Lck are brought into a high
local concentration to interact and initiate signaling.
For technical reasons, and an incomplete understanding of the
processes outlined above, few studies have reported measuring
these events. Therefore, much of what we discuss below will be
based on calcium mobilization data. This is a commonly used
measure of TCR-proximal signaling events that has been reviewed
extensively elsewhere (Hogan et al., 2010). This event is down-
stream of the initial ITAM phosphorylation events outlined above
and occurs rapidly after TCR engagement (Huse et al., 2007). In
addition, it can occur in response to as few as one agonist pMHC
(Irvine et al., 2002; Purbhoo et al., 2004). Thus, it is a sensitive
readout of TCR engagement and signaling even though it not a
direct measurement of the events outlined above.
It is of note, however, that the molecular mechanisms that ini-
tiate transient signaling in response to low ligand densities may
be less complex than those that drive T cells to secrete cytokines
and proliferate. TCR signaling must be sustained for several hours
in order for T cells to reach this more classically defined state of
T cell activation (Huppa et al., 2003). Understanding the molec-
ular mechanisms by which sustained TCR-CD3 signaling informs
T cell fate decisions is, for us, a natural extension of asking how
TCR signaling begins. As with any complex mechanical or mole-
cular machinery, understanding how the parts of this machinery
fit and work together is key to unraveling the mystery of how they
function. We think it is likely that “full activation” results from a
multi-step process for assembly of, and signaling through, these
modular biosensors.
THE MOLECULAR ARCHITECTURE OF THE TCR-CD3 COMPLEX
Determining the structure of an intact TCR-CD3 complex at
atomic resolution will represent a major step forward in our
understanding of the form and function of this macromolecular
machine. However, there are severe technical challenges associated
with working on a complex composed of eight polypeptides that
associate through a continuum of transmembrane and extracel-
lular interactions (Call and Wucherpfennig, 2005; Kuhns et al.,
2006; Kuhns and Davis, 2007). In addition, the mechanistic basis
for TCR triggering may involve a change of the ECD of the subunits
with respect to each other and/or the outer leaf of the membrane
(Kuhns et al., 2006). This could occur as a consequence of some
sort of force being induced by pushing or pulling upon pMHC
engagement that ultimately changes the orientation of the intra-
cellular domains of the CD3 ITAMs with respect to the inner leaf
of the membrane. If so, then static structures of unliganded and
liganded complexes removed from their native environment, and
in the absence of a source of counter posing force, may not reveal
the mechanistic basis for triggering. Indeed, it is generally accepted
that monomers of pMHC do not induce TCR signaling. Clearly,
there is a long road ahead regarding an atomic level picture of
this complex in action. Nevertheless, progress from a number of
groups is allowing us to piece together a sketch of the complex
architecture.
A great deal of structural information has been acquired regard-
ing the individual parts of this molecular machine (Kuhns et al.,
2006). The first crystal structure of the TCR ECD revealed that
the TCR is remarkably similar to a Fab fragment of an antibody
(Garcia et al., 1996). The clonotypic TCRα and TCRβ variable
(Vα and Vβ) domains adopt classic Ig-folds that associate via their
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bottom beta-sheets. The TCRβ constant domain (Cβ) also adopts
an Ig-fold and associates with the bottom beta-sheet of the TCRα
constant domain (Cα). Interestingly, the Cα domain has a clear
Ig-fold ancestry but deviates structurally from the Vα, Vβ, and Cβ
domains due to its lack of a top beta-sheet. Instead, it has two
loosely associated top strands that expose an apolar pocket, remi-
niscent of a protein interaction hot spot (DeLano et al., 2000). The
evolutionary pressures that caused this structural divergence are
unknown. But, our recent data suggests that this unusual struc-
ture plays a role in mediating homotypic TCR interactions (Kuhns
et al., 2010). The connecting peptides that span from the Cα and Cβ
domains to the membrane are also quite interesting due to their
unusually length (∼20 amino acids). No structural information
is available for these segments of the TCR extracellular regions,
but they have been implicated in complex assembly, stability, and
signaling (Backstrom et al., 1996, 1997; Werlen et al., 2000; Nae-
her et al., 2002; Mallaun et al., 2008). The solution and crystal
structures of the ECD of CD3δ, γ, and ε also reveal Ig domains
(Sun et al., 2001, 2004; Arnett et al., 2004; Kjer-Nielsen et al.,
2004). Interestingly, the subunits of each heterodimer associate
via the intra-strand loops in a side-by-side manner. In contrast to
the TCR heterodimer, CD3γε and CD3δε have short, rigid con-
necting peptides with RxCxxCxE motifs that facilitate pairing of
these heterodimers and play a role in signaling (Sun et al., 2001;
Martinez-Martin et al., 2009; Wang et al., 2009b). The transmem-
brane domains of each complex subunit are predicted to form
alpha helices that are known to associate via a complex network of
electrostatic interactions. The solution structure of the transmem-
brane domains of CD3ζζ in SDS micelles does reveal helices that
run parallel through the membrane with a small crossing angle
(Call et al., 2006). Likewise, by analogy, the solution structure
of a NKG2C transmembrane helix interacting with two DAP12
helices suggests that the associating TCRα-CD3δε and TCRβ-
CD3γε transmembrane helices are likely to form a tight trimer of
parallel non-crossing helices through the membrane (Call et al.,
2010). Finally, as first proposed by Stern and colleagues (Aivazian
and Stern, 2000), the intracellular domains of CD3ε and CD3ζ,
but not CD3γ or CD3δ, contain stretches of basic residues that
are thought to facilitate interactions with the acidic inner leaf
of the membrane. These interactions are thought to protect the
critical tyrosines of the ITAMs from Src kinase phosphorylation
when the TCR is unliganded (Aivazian and Stern, 2000; Sigalov
et al., 2006; Xu et al., 2008; Deford-Watts et al., 2009; DeFord-
Watts et al., 2011; Zhang et al., 2011); however, paradoxically,
these polybasic stretches are also important to facilitate signaling
(Deford-Watts et al., 2009; DeFord-Watts et al., 2011; Zhang et al.,
2011). Altogether, these individual pieces of information provide
important insights into the structural characteristics of the key
components of the TCR-CD3 complex. But, with the exception of
the transmembrane domain data, they provide very few insights
into how the TCR and CD3 subunits fit together to form a mole-
cular machine that can transfer pMHC-specific information from
the outside to the inside of a cell.
When we last reviewed this topic we highlighted all of the
potential extracellular TCR-CD3 interaction sites that had been
proposed at that point in time. The state of the field had lead
us to conclude that nearly any conceivable TCR-CD3 complex
architecture could have been possible (Kuhns et al., 2006). Exper-
iments performed by the Wucherpfennig and colleagues had
clearly shown the stoichiometry of a nascent complex to be
1TCR:1CD3γε:1CD3δε:1CD3ζζ (Call et al., 2002). Furthermore,
due to the periodicity of the transmembrane helices that play
an important role in mediating complex assembly, the TCRα-
CD3δε and TCRα-CD3ζζ transmembrane interactions would be
spaced roughly 140˚ from each other. But, there was no informa-
tion regarding the relationship between the turns of the trans-
membrane helices and the ECD that could provide insights
into the spatial relationship between the ECD of the TCR and
CD3 subunits. In addition, while antibody-mapping data sug-
gested that one of the CD3ε subunits resides in close proxim-
ity to the distinctive FG loop of TCRβ (Ghendler et al., 1998),
and crosslinking data also placed the ECD domain of CD3γ in
close associate with TCRβ (Brenner et al., 1985), no experimen-
tal data existed for the relationship between TCRα and CD3δε
or CD3δε and CD3γε. Thus, we undertook a reverse engineer-
ing project to determine the spatial relationship between the
ECD of the TCR and CD3 heterodimers (Kuhns and Davis,
2007).
In order to deconstruct and deduce how the ECD domains of
the TCR and CD3 heterodimers fit together, we generated TCRs
mutated on distinct solvent-accessible surfaces of the Cα and
Cβ domains (Kuhns and Davis, 2007). We found that mutating
the highly conserved CαDE loop destabilizes TCR-CD3δε interac-
tions in co-immunoprecipitation experiments, suggesting that the
Cα DE loop composes a portion of the extracellular interaction
site with TCRα. We also observed that mutations in the highly
conserved Cβ CC′ loop, which is adjacent to the Cα DE loop on
one side of the TCR, weakened the association between the TCR
and both CD3 heterodimers. This phenotype was similar to that
observed by the Reinherz group when they deleted the FG loop
(Touma et al., 2006), suggesting that both the Cβ FG and CC′ loops
contribute to TCR-CD3 complex stability. By extension, this indi-
cates that the face of the Cβ domain bordered by these loops is the
likely site for extracellular TCR-CD3γε interactions. Importantly,
the close proximity of the Cα DE and Cβ CC′ loops, the similar
phenotypes of our Cβ CC′ loop mutant and the FG loop deletion,
and data from Call et al. (2002) showing that TCR-CD3δε interac-
tions occur normally in the absence of CD3γεbut that TCR-CD3γε
interactions require TCR-CD3δε interactions, lead us to postulate
that relatively strong TCR-CD3δε interactions form a compos-
ite binding surface for TCR-CD3γε interactions. One important
prediction of this model was that mutating both the Cα DE and
Cβ CC′ loops should completely destabilize the TCR-CD3 com-
plex. This is in fact what we observed in our immunopreciptiation
experiments. These data were consistent with our hypothesis that
the CD3 heterodimers are clustered on one side of the TCR. And, of
note, very recent mutagenesis experiments independently confirm
this location (Fernandes et al., 2012).
We next used a kinase-based dimerization assay to indepen-
dently verify that the two CD3 heterodimers are clustered on one
side of the TCR. This was important for two reasons: (i) our model
was controversial because the dominant model at the time docked
the CD3 heterodimers on opposite sides of the TCR (Sun et al.,
2004); (ii) our mutagenesis data did not provide any information
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about the specific spatial arrangement of these CD3 subunits with
respect to each other (Kuhns and Davis, 2007).
This assay operates on two key principles/components
(Yamasaki et al., 2006). The first takes advantage of the signaling
mechanism of the erythropoietin receptor (EPOR). In the unli-
ganded state, EPOR exists as a homodimer with the intracellular
signaling domains held ∼70 Å apart (Livnah et al., 1999). Upon
ligand engagement, these domains are brought within ∼40 Å of
each other. This conformational change brings the two signaling
domains and their constitutively associated Jak2 molecules into
juxtaposition. In turn, the two Jak2 molecules are positioned to
directly interact and transautophosphorylate. BaF3 cells are the
second key component of this system. These cells are dependent
upon Jak-Stat signaling for growth. Thus, chimeric proteins con-
taining the intracellular signaling domains of EPOR will drive
BaF3 cell growth if two EPOR domains are positioned within
∼40 Å of one another. For our experiments, we generated a poly-
cistronic construct encoding truncated CD3 subunits with the
picornavirus 2A cleavage system, similarly to that pioneered by
Vignali and colleagues (Szymczak et al., 2004). The subunits lacked
all of the ITAMs in order to eliminate the potential for any signaling
through these domains. Variants of this construct were then gener-
ated encoding chimeras in which the EPOR intracellular signaling
domain was fused directly to the last transmembrane residue of
CD3δ, γ, or ε. We also generated constructs encoding both CD3δ
and CD3γ fused to EPOR. Each CD3 construct was then expressed
in BaF3 cells in the presence or absence of TCRα and TCRβ. The
results of these experiments were consistent with the CD3 het-
erodimers being clustered on one side of the TCR. Specifically, they
showed that the two CD3ε domains are juxtaposed upon assem-
bly of the TCR-CD3 complex because the CD3e-EPOR chimera
drove BaF3 growth in a TCR dependent manner (Kuhns et al.,
2010). The CD3δ- and CD3γ-EPOR chimeras did not drive BaF3
growth in a TCR dependent manner and therefore are unlikely to
be positioned next to each other as has been recently proposed
(Fernandes et al., 2012). The TCR-CD3 complex architecture that
is most consistent with the sum of the existing experimental data is
one in which CD3δε and CD3γε associate with the TCR in an open
face orientation. They dock on the side of the TCR that includes
the Cα DE and Cβ CC′ loops in the order δ:ε:ε:γ (Figure 1; Kuhns
et al., 2010). The periodicity of the TCRα transmembrane helix
and the spacing (∼140˚) of the key charged residues that mediate
interactions with CD3δε and CD3ζζ indicates that CD3ζζ resides
on the opposite side of the TCR.
Our understanding of the architecture of a complex in iso-
lation is rounded out by data indicating that the intracellular
domains of CD3ε and CD3ζ, but not CD3δ and CD3γ, associate
with the acidic inner leaf of the membrane (Aivazian and Stern,
2000; Sigalov et al., 2006; Kuhns and Davis, 2008; Xu et al., 2008;
Deford-Watts et al., 2009; DeFord-Watts et al., 2011; Zhang et al.,
2011). Several features are note worthy when all of these data are
considered in aggregate. The picture that is taking shape is one in
which the two CD3ε intracellular domains emerge from the mem-
brane side-by-side and interact with the acidic inner leaf of the
membrane (Figure 1). The CD3γ and CD3δ intracellular domains
would emerge from the membrane to flank the CD3ε intracellular
domains on one side of the TCR. CD3ζζ would emerge from and
associate with the acidic inner leaf of the membrane below the
unique surface of the Cα domain on the other side of the TCR
(Kuhns et al., 2010). Thus, the four ITAMs (one each for CD3γ, δ,
and ε) of the CD3γε/CD3δε signaling module and the six ITAMs of
the CD3ζζ signaling module (three per chain) reside on opposite
sides of the TCR.
THERE IS A FUNCTIONAL SIDEDNESS TO THE TCR
A discussion of how the function of this complex is influenced by
its architecture requires an introduction to the idea that TCR-CD3
multimerization plays a role in signaling. Dimerization, higher-
order multimerization, and/or general clustering of the TCR-CD3
complex have long been thought to be a key aspect of TCR signal-
ing. Consequently, it is a concept that will be discussed at various
points herein.
The connection between TCR-CD3 complex clustering and
signaling has its origins in crosslinking studies performed with
anti-TCR or anti-CD3 monoclonal antibodies (mAbs) that induce
cytokine secretion or T cell proliferation (Rojo and Janeway, 1988;
Yoon et al., 1994; Janeway, 1995). These data suggest that there
are geometric constraints placed on signaling induced by cluster-
ing, meaning that random clustering is insufficient for signaling.
More recent studies using inventive approaches to crosslink TCR-
CD3 complexes with antibodies or soluble pMHC dimers, trimers,
or tetramers also support the notion that forcing TCR-CD3 com-
plexes together can lead to signaling (Boniface et al., 1998; Cochran
et al., 2000; Krogsgaard et al., 2005; Minguet et al., 2007). These
reagents and experimental approaches have been extremely helpful
in establishing what parameters might play a role in signaling; they
have also been very useful in studying the intracellular signaling
cascades that connect the complex to the nucleus (Smith-Garvin
et al., 2009). However, they have not addressed the issue of geo-
metric constraints. Also, as discussed later, the fact that mitogenic
reagents such as mAbs or more physiological reagents such as
multimerized pMHCs can force TCR-CD3 complexes together
and induce signaling does not prove that higher-order TCR-CD3
complexes plays a role in signaling when the TCR engages cognate
pMHC. The evidence for direct homotypic interactions between
soluble TCRs upon binding pMHC has been decidedly mixed
(Reich et al., 1997; Alam et al., 1999; Baker and Wiley, 2001). Thus,
the role of TCR-CD3 complex dimerization or higher-order mul-
timerization in recognition of pMHC on APCs remains a question
of great significant in need of further inquiry and clarification.
We have used the kinase-based assay outlined above to address
this problem. The data represent the first evidence for TCR–TCR
interactions in the cell membrane, and thus the first insights into
the architecture of higher-order TCR-CD3 complex assemblies
(Kuhns et al., 2010). In addition, using mutagenesis we mapped the
regions mediating these interactions to the surface of the unusual
Cα domain composed of the C and F strands as well as the AB loop
(Figure 1). Interestingly, the sum of the data discussed to this point
position the CD3ζζ subunits immediately below this surface in a
single TCR-CD3 complex. Furthermore, it would place two CD3ζζ
homodimers at the interface between two TCR-CD3 complexes.
These data are in-line with an increasing body of evidence that
suggest a link between the geometric organization of TCR-CD3
complexes, and their function, upon ligand engagement.
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FIGURE 1 |The architecture of theTCR-CD3 complex. (A)The αβTCR is
shown (PDB: 1TCR) as a surface rendered structure with the variable (V)
regions on top and the constant (C) regions on the bottom. The constant
region surfaces discussed herein are colored: Cα AB loop (green), Cα C
strand (yellow), Cα DE loop (cyan) Cα F strand (red), Cβ CC′ loop (orange),
and Cβ FG loop (pink). (B) A top down view of the transmembrane
domains, with red and blue dots indicating the acidic and basic
transmembrane charge residues (respectively) that mediate assembly of
the complex (Call et al., 2002; Kuhns and Davis, 2007; Kuhns et al.,
2010). (C) A front-on view of the extracellular (ECD), transmembrane
helices (TM), and intracellular (ICD) domains according to our current
interpretation of the existing data. The subunits are color coded as
labeled: TCRα (white), TCRβ (magenta), CD3γ (orange), CD3δ (cyan),
CD3ε (marine).
We coupled functional studies with our structural analysis in
order to contribute to our understanding of this link. Importantly,
we observed that mutations that destabilize extracellular TCR-
CD3 interactions on one side of the TCR and those that impair
TCR dimerization on the other each have distinct impacts on TCR
signaling (Kuhns and Davis, 2007; Kuhns et al., 2010). More specif-
ically, mutations in the Cα DE loop that destabilize TCR-CD3
complex stability lead to a significant lag in the time between T
cell contact with a peptide-pulsed APC and intracellular calcium
mobilization, suggesting that complex stability is important for
how TCR signaling begins. But, these mutations did not impact T
cell polarization to the site of antigen contact or immunological
synapse (IS) formation. In contrast, impairing dimerization with
mutations in either the Cα, C, or F strands had minor impacts on
the initial magnitude, but not the kinetics of calcium flux; how-
ever, these mutations significantly impaired IS formation and T
cell polarization toward the site of antigen engagement. We con-
cluded from these studies that there is a functional sidedness to the
TCR at the nucleus of each TCR-CD3 complex and that the inter-
actions mediated by its constant domains play important roles
in TCR signaling (Kuhns et al., 2010). A better understanding of
how this functional sidedness contributes to signaling requires a
more in-depth understanding of how monomers and dimers of the
complex fit within the higher-order macromolecular machinery
responsible for full TCR signaling.
MACROMOLECULAR COMPLEXES AND GEOMETRIC
CONSTRAINTS ON TCR SIGNALING
The TCR-CD3 complex is the primary component of the mole-
cular machinery that transfers pMHC-specific information from
the outside of a T cell to the intracellular signaling apparatus, but
it cannot efficiently complete this task in isolation. The complex
fails to activate T cells when confronted with monomeric pMHC
in solution. Yet, it is not known if this is because the complex is
unable to make the ITAMs accessible to Lck when bound to a sol-
uble monomer, if a monomer is unable to successfully recruit Lck
to the ITAMs, or both. A single agonist pMHC on an APC can
elicit a transient, co-receptor-dependent calcium flux in CD4+
and CD8+ T cells (Irvine et al., 2002; Purbhoo et al., 2004). Sus-
tained calcium mobilization requires 10 pMHC on an APC as well
as co-receptors, whereas more than 20 pMHC complexes must
be present on an APC before the TCR-CD3 complex can sustain
calcium mobilization in the absence of a co-receptors. Similarly,
on a planar bilayer a single agonist pMHC only elicits a transient
calcium flux (Ma et al., 2008b). More recently Manz et al. (2011)
used partitioned planar bilayers, where the total number of ago-
nist pMHC encountered by cells are the same, to show that an
average concentration of one pMHC per partition cannot induce
half-maximal calcium flux whereas two pMHC per partition can.
Importantly, the authors calculated that at an average concentra-
tion of one pMHC per partition there was a high probability of
TCR clusters encountering two pMHC. At an average concentra-
tion of two pMHC per partition the probability of a triggering
TCR cluster encountering more than two pMHC is sufficiently
high to conclude that the minimal triggering unit per partition
in this experimental system to induce half-maximal calcium flux
was four to six agonist pMHC. In other systems it has been shown
that soluble pMHC dimers, trimers, and tetramers can also induce
TCR signaling in a co-receptor dependent manner (Boniface et al.,
1998; Cochran et al., 2000; Krogsgaard et al., 2005). Each of these
experimental systems have strengths and weaknesses and there are
finer points to be argued. Nevertheless, the existing data indicate
that sustained TCR signaling requires the assembly of higher-order
TCR-CD3 complexes, co-receptors, and multi-valent arrays of 2+
agonist pMHC. These macromolecular assemblies are not likely
to come together randomly. Rather, the structural and mutagene-
sis data accumulated to date point to geometrically constrained
macromolecular complexes mediating sustained TCR signaling
(Figure 2).
TCRs bound to pMHC are the cornerstones of these assemblies.
One of the most interesting observations to come out of the com-
parison of a number of TCR-pMHC crystal structures is that the
assembly of this basic building block is not random (Rudolph et al.,
2006; Garcia et al., 2009). Instead, the structures of productive
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pMHC I 
CD8
CD8+ T cell 
CD4 
CD8
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pMHC II 
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FIGURE 2 |The multi-molecularT cell signaling machinery. Shown is the
state of the field as we understand it regarding the multi-molecular
higher-order assemblies that mediate sustained TCR signaling on CD4+ (left)
and CD8+ (right) T cells (Garcia et al., 1996, 2009; Sun et al., 2001, 2004;
Wang et al., 2001, 2009a; Call et al., 2002; Arnett et al., 2004; Kjer-Nielsen
et al., 2004; Kuhns and Davis, 2007; Kuhns et al., 2010).
TCR-pMHC interactions indicate that there is a canonical docking
polarity driven by germline-encoded interactions that Garcia et al.
(2009) have termed “interaction codons.” Interestingly, in spite
of these apparent restrictions, highly conserved germline contacts
still allow for great diversity in specificity and affinity of TCR-
pMHC interactions due to significant diversity and flexibility in
the CDR3 loops (Newell et al., 2011).
As we have previously noted, this docking polarity will fix
the relationship between the CD4 or CD8 co-receptors and the
CD3 subunits within a TCR-CD3 complex (Kuhns and Davis,
2007); specifically, the CD3 heterodimers will always be on the
same face of a TCR-pMHC unit as the docking sites for the CD4
or CD8 co-receptors on class I or class II pMHC, respectively,
that have been identified by crystal structures and/or mutage-
nesis (Konig et al., 1992; Wang et al., 2001, 2009a; Yin et al.,
2012). Dimerization of TCR-CD3 complexes would extend onto
this base unit via the opposite face of the TCR, which is com-
posed of the unusual Cα surface (Kuhns et al., 2010). Recent
data also suggests that intercomplex transmembrane interactions
between CD3ζζ homodimers play a role in stabilizing oligomers
of TCR-CD3 complexes (Kumar et al., 2011). Thus, the core of
this stable signaling unit would consist of at least two mirror-
ing TCR-CD3-pMHC units. For class II MHC specific T cells, the
CD4 co-receptor is thought to assume a V-like relationship with
respect to the TCR-CD3-pMHC unit. This is based on a crystal
structure of the D1 and D2 domains of CD4 in association with
class II MHC (Wang et al., 2001) as well as a recent report of
the ternary complex of a pMHC bound to a TCR and an affinity
maturated CD4 (Yin et al., 2012). It should be noted however that
CD4 has also been proposed to interact directly with the TCR-CD3
complex. This may appear in conflict with a V-like organization.
But, the side-chains of the residues identified by mutagenesis that
impaired CD4 function were either completely or partially buried
in the hydrophobic core of the D3 Ig-fold; thus, decreased CD4
function could have reflected destabilized CD4 molecules rather
than TCR-CD4 interactions (Vignali et al., 1996; Vignali and Vig-
nali, 1999). Alternatively, CD4 may directly interact with a TCR
that is not engaged to the same pMHC through a “pseudodimer”
type orientation (Irvine et al., 2002). In such a scenario, the base
unit illustrated in Figure 2 could serve as a nucleus from which
higher-order macromolecular assemblies branch out (not shown).
Likewise, CD4 has been observed to crystallize as a homodimers
in the D4 domain and mutagenesis data suggest that this is bio-
logically relevant for CD4 function (Wu et al., 1997; Moldovan
et al., 2006). This may also provide a mechanism for an outgrowth
of higher-order assemblies from this core TCR-CD3-pMHC-CD4
unit. The CD8 heterodimer, with its long tethers, is thought to
hang down in close proximity to the TCR-CD3 complex, and some
studies indicate that it interacts with CD3δ or TCRα (Naeher et al.,
2002; Doucey et al., 2003; Mallaun et al., 2008).
A variety of functional studies also support the macromolecu-
lar models shown in Figure 2. TCR signaling clearly begins when
TCRs bind cognate pMHCs, and these interactions are required
to initiate and sustain signaling. The central role of the canoni-
cal docking polarity to the proper assembly of macromolecular
signaling units predicts that any TCRs found to deviate from
this polarity should signal poorly or not at all. Two autoreactive
TCRs, specific for myelin basic protein (MBP)-derived peptides
presented in the class II MHC HLA-DR2, that are presumed to
have escaped negative selection by signaling poorly do deviate
from the norm in their docking configurations (Hahn et al., 2005;
Li et al., 2005). Both are unusual in that they are docked over the
N-terminal half of the peptide, rather than the central portion of
the peptide. This could place the CD3 ITAMs, and particularly
those for CD3ζζ, at a greater distance from the CD4 associated
Lck and may lead to incomplete phosphorylation during pMHC
engagement. In addition, one of these TCRs docks at an angle
that the authors proposed might impair the proper spatial rela-
tionship with CD4 and thus impair CD4 function (Hahn et al.,
2005). More recent structural data supports this view (Yin et al.,
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2012). Very recently, Garcia and colleagues have used an elegant
yeast display approach to circumvent the selective pressures of
the thymus, including any co-receptor constraints, and identified
a peptide (p3A1) that is recognized by the 42F3 TCR when pre-
sented by H2-Ld via a docking configuration that significantly
deviates from the norm (Adams et al., 2011). Importantly, this
pMHC complex can bind the 42F3 TCR, as measured by sur-
face plasmon resonance, with an affinity that should be activating
when compared with other known agonist TCR-pMHC interac-
tions. But presentation on an APC fails to induce signaling through
the 42F3 TCR. This finding represents a major advance in our
understanding of how TCR signaling is initiated because it lends
critical experimental support to the idea that signaling not only
begins with TCR-pMHC engagement, but that it can only occur
if a specific docking polarity is achieved. Whether the unusual
docking of 42F3 on the p3A1-Ld complex prevents the transfer
of information from the binding interface to the ITAMs, prevents
dimerization of the TCR-CD3 complex, prevents recruitment of
CD8-associated Lck to the ITAMs, or all of the above remains to
be determined.
CD4 or CD8 are also critical for the initiation of TCR sig-
naling, particularly to low density and low affinity ligands. As
clearly demonstrated by Singer and colleagues, the co-receptors
provide binding and signaling specificity to MHC by sequestering
Lck away from the TCR until the TCR engages cognate pMHC;
consequently, they have also been proposed to play a key role in
modulating TCR signaling (Van Laethem et al., 2007). The exist-
ing structural and mutagenesis data, which largely overlap in their
determination of the general location where the co-receptors bind
MHC, indicate that there are specific surfaces on class I and class
II MHC bound by either CD8 or CD4, respectively, to recruit
Lck to the TCR-CD3 complex (Potter et al., 1989; Salter et al.,
1990; Konig et al., 1992; Wang et al., 2001, 2009a; Yin et al., 2012).
Mutagenesis of the CD4 or CD8 binding sites on their respective
MHC ligands abrogates signaling, presumably because this pre-
vents recruitment of Lck to the ITAMs and favors sequestration
of Lck away from the complex by the co-receptor (Potter et al.,
1989; Salter et al., 1990; Konig et al., 1992). Given that a signif-
icant fraction of the Lck within T cells has been determined to
be in an active state (Nika et al., 2010), sequestering Lck away
from the ITAMs is likely to be of critical importance to keeping
the complex off when agonist pMHC is not present (Van Laethem
et al., 2007). This would also allow for a hair trigger response
when antigen is encountered. It is interesting, when looking at
Figure 2, to wonder whether CD4 and CD8 contribute in the
same manner to TCR signaling. It is difficult to understand how
CD4 associated Lck is capable of reaching and phosphorylating
all of the CD3ζζ ITAMs. But, Förster resonance energy (FRET)
pairs at the C-terminus of CD4 and the C-terminus of CD3ζζ do
transfer energy, suggesting that these domains can come within
close proximity of each other (Zal et al., 2002). In addition, par-
ticularly if CD8 does directly interact with the complex via the
TCRα connecting peptide (Mallaun et al., 2008), it is interesting to
consider if the co-receptors play some role in making the ITAMs
accessible to Lck in addition to recruiting the kinase to its sub-
strate. In any event, the co-receptors are clearly key components
of the macromolecular machinery important for the initiation of
TCR signaling and without them we may be addressing a very
different question, or approaching this issue in a very different
way.
Finally, as discussed above, we have shown that mutations in the
unusual top strands of the Cα domain that disrupt TCR dimeriza-
tion also impair TCR signaling, and in particular those signals that
lead to cytoskeletal polarization and IS formation (Kuhns et al.,
2010). Schamel and colleagues have also implicated TCR dimer-
ization as an important component of TCR signaling (Minguet
et al., 2007) and, more recently, it has been reported that mutations
in transmembrane domain residue of CD3ζ that appear to stabi-
lize dimerization or oligomerization of TCR-CD3 complexes also
impair TCR signaling (Kumar et al., 2011). Together, these data
build a strong case for a role of TCR dimerization in signaling.
But, as discussed in greater detail below, it is unclear if dimeriza-
tion is necessary to initiate signaling or if it is more important for
sustained signaling.
Overall, the state of the field both structurally and functionally
can be illustrated as shown in Figure 2. This represents our best
approximation of the nature of the basic unit of higher-order
macromolecular assemblies that initiate and/or sustain robust
TCR signaling on CD4+ and CD8+ T cells. Intriguingly, it sug-
gests that slightly different mechanisms might be employed for
CD4 versus CD8 assisted signaling due to the potential spatial dif-
ferential between the co-receptors-associated Lck recruited to the
complex and the CD3 ITAMs.
MECHANICAL FORCE, DIMERIZATION, OR BOTH
Is the assembly of all of the parts, as illustrated in Figure 2, impor-
tant to initiate signaling, required for sustained signaling, or both?
These are important distinctions to consider because the require-
ments for initiating a transient stop signal upon contact to scan
the pMHC on the surface of an APC may not be as complex
as the requirements for the sustained signaling that is necessary
for cytokine production and proliferation. As we have previously
discussed (Kuhns et al., 2006), the reigning models for how sig-
naling begins involve some sort of conformational change of the
TCR-CD3 complex subunits with respect to each other and/or
the membrane; TCR dimerization is also commonly proposed.
But, little attention has been paid to whether or not the molecular
assemblies required for transient signaling versus sustained signal-
ing may be different. Nevertheless, a variety of recent functional
studies have provided us with some important clues upon which
to evolve our thinking regarding how TCR signaling is initiated
versus how it may be sustained.
First, when the stability of the TCR-CD3 complex or the rigid-
ity of the CD3ε stalks have been compromised signaling has been
compromised (Backstrom et al., 1996, 1998; Sun et al., 2001; Sasada
et al., 2002; Touma et al., 2006; Kuhns and Davis, 2007; Wang et al.,
2009b). These data do not support models in which the ECD of the
complex subunits undergo a conformational change with respect
to each other to transmit information across the cell membrane.
But, they make a strong case for the idea that the subunits of
the complex move as a unit to undergo a conformational change
with respect to the membrane under the influence of a mechani-
cal force presumably exerted by the cytoskeleton. This force would
push and/or pull the complex upon engagement of pMHC on the
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surface of an APC (Sun et al., 2001; van der Merwe, 2001; Kuhns
et al., 2006; Kuhns and Davis, 2007; Ma et al., 2008a).
As we have speculated before, the architecture of the complex
is interesting with respect to mechanical force models because
the TCR may be thought to resemble a lever with the CD3 het-
erodimers serving as a wedge at its base (Kuhns and Davis, 2007).
The unusual stalks of the CD3 heterodimers, with their RxCxxCxE
motifs, have been proposed to stiffen to transfer force through the
membrane (Sun et al., 2001; Martinez-Martin et al., 2009). So,
we can envision a potential mechanism for TCR-CD3 complex
signaling similar to that by which a classic-style water cooler nor-
mally retains water and then transfers it from one reservoir to
another in response to force (Figure 3). In short, pushing down
on a water cooler lever causes the lever to pivot over the top of
its protruding base as one unit. This causes the valve in the back
to be pulled upward and open to allow water to flow. Likewise,
TCR engagement of pMHC on an APC might cause the TCR to
pivot over the top of the CD3 heterodimers, moving as a unit,
to push the CD3γε and CD3δε down while also pulling up on the
CD3ζζ situated on the opposite side of the complex. This opposing
action would allow pMHC-specific information to flow across the
membrane. Such a mechanism would cause the transmembrane
domains to pivot with respect to each other, as has previously been
proposed (Engelman, 2003). Importantly, given that a 1-Å change
of transmembrane domains with respect to each other can induce
signaling in the aspartate receptor (Ottemann et al., 1999), any
type of lever-like pivot may not have to be particularly extreme to
relay pMHC-specific information across the cell membrane. The
co-receptors may contribute force in this model by holding the
pMHC in a particular orientation with respect to the TCR and/or
the membrane. This “water cooler” model is one of several ways
in which a mechanical force may be transmitted across the mem-
brane and testing such models will likely provide insights into
how the critical tyrosines of the CD3ε and CD3ζζ ITAMs are made
accessible for Src kinase phosphorylation.
Several lines of evidence suggest that a single pMHC can elicit a
signaling event (Irvine et al., 2002; Purbhoo et al., 2004; Ma et al.,
2008b); however, as introduced above, dimerization or oligomer-
ization of the TCR-CD3 complex has long been considered a
possible mechanism for signaling (Symer et al., 1992; Reich et al.,
1997; Boniface et al., 1998; Alam et al., 1999; Cochran et al., 2000).
It is not immediately obvious why dimerization would be nec-
essary. The complex has 10 ITAMs that are already pre-clustered
within a single complex and it only lacks an intrinsic Src kinase
activity with which to modify the ITAMs. So, it is not clear why
there would be a need to bring more ITAMs together to initiate
signaling given the high concentration of signaling substrates in
one complex.
The failure of soluble pMHC monomers to activate T cells may
be taken as evidence that multi-valent arrays are important to
facilitate TCR dimerization and signaling. Yet, this would also be
consistent with a requirement for force to be transmitted across a
membrane. A force requirement is more difficult to reconcile with
the fact that soluble pMHC dimers can activate T cells (Cochran
et al., 2001). The increased avidity of the dimer and potential con-
straints imposed by the linker may result in some sort of torque
being transmitted through the TCR-CD3 complex upon pMHC
A
B
FIGURE 3 |The water cooler model ofTCR triggering. (A) Cartoons of a
“classic-style” water cooler in action. The valve is closed on the left and
water is retained in the tank. Once the lever is pushed down it pivots over
its rigid base (right), causing an upward pull on the attached valve. This
opposing action opens the valve and allows water to flow from the tank. (B)
An analogous mechanism may trigger the flow of pMHC-specific
information from the outside to the inside of a T cell. A cartoon of the basic
triggering components is shown, similarly to Figures 1 and 2. The
unengaged TCR-CD3 complex on the left is relatively upright. Upon ligand
engagement (right), the TCR pivots over the rigid CD3 heterodimers at its
base, possibly pushing them into the membrane while pulling up on the
CD3ζζ on the opposite side of the complex.
engagement. This could be facilitated and/or enhanced by the
co-engagement of the pMHC dimers by TCRs and co-receptors,
which are required for activation with dimers (Krogsgaard et al.,
2005), such that the constraints of adopting a higher-order macro-
molecular structure by the TCR-CD3 complex, co-receptor, and
pMHC could cause a force to be transmitted across the membrane.
Alternatively, triggering may not involve a change in the confor-
mation of the complex with respect to the membrane under force.
Rather, the relative stability and/or rigidity of the complex as a
whole, as well as a canonical TCR-pMHC docking motif, may be
important for the natural process of TCR dimerization; soluble
dimers may simply force two TCRs together to induce signaling in
a non-physiological manner. Clearly, any discussion of TCR signal-
ing warrants further consideration of the role of TCR dimerization
in how TCR signaling begins or is sustained.
As is often the case when the number of models for a process
outstrip the data, key aspects such as geometric constraints, force,
and dimerization or higher-order oligomerization are all likely to
be at least partially correct. Indeed, there are data to support each
of these mechanisms. While it is known that TCR-CD3 complexes
are co-associated spatially in protein islands in the T cell mem-
brane (Schamel et al., 2005; Lillemeier et al., 2006, 2010; Kumar
et al., 2011) it is not known to what extent unliganded TCRs are
physically engaged in homotypic protein: protein interactions in
the absence of ligand engagement. As reviewed by Dustin and
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Depoil (2011), this is an entirely different scale, at the molec-
ular level, rather than the much larger units of protein islands,
micro clusters, or macro clusters described by various imaging
techniques.
We interpret the existing TCR dimerization data as suggesting
that TCR: TCR interactions via the Cα top strands are of low affin-
ity and stabilized upon ligand engagement (Kuhns et al., 2010);
thus, homotypic TCR dimers may normally be stabilized, particu-
larly at high ligand densities, within higher-order macromolecular
signaling units after TCR and co-receptor engage pMHC and
transmit a force across the membrane. Soluble dimers might be
able to induce TCR signaling at high concentrations by skipping
the step that normally requires mechanical force when dispersed,
and low density, pMHC is encountered on an APC. Dimers would
simply force two TCR-CD3 complexes together. We suggest this
possibility because neither our mutant TCRs that destabilize the
complex, and presumably impair the transfer of force through
the complex, nor those that impair TCR dimerization, com-
pletely abrogate signaling (Kuhns and Davis, 2007; Kuhns et al.,
2010). Rather, as noted above, when we measured calcium flux
we observed that destabilizing the complex leads to a significant
delay in both the onset and initial magnitude of intracellular cal-
cium mobilization after first T cell contact with an APC pulsed
with high concentrations of agonist peptide. In contrast, impair-
ing TCR dimerization only slightly reduces the magnitude of the
initial influx of calcium mobilization in the same experimental
system. This suggests that a stable complex, and presumably a
transfer of force, is more important for the initiation of signaling
than dimerization when a T cell encounters cognate ligand on an
APC. Thus, the use of soluble dimers as a stimulant may limit the
mechanisms by which the cells can signal. In contrast, when the
cells are confronted with agonist pMHC on an APC, particularly
at low or dispersed ligand densities they may preferentially employ
other mechanisms, such as force, to initiate calcium mobilization.
Such a discrimination of force and dimerization steps might
explain why endogenous co-agonist peptides appear to have a
greater observed impact on the frequency of T cells that flux
calcium in response to soluble dimers of agonist and co-agonist
peptides than when the co-agonist peptides are presented on a
planar bilayer with agonist pMHC (Krogsgaard et al., 2005; Ma
et al., 2008b). Interestingly, under conditions where the agonist
and co-agonist peptides are immobilized on planar bilayers the
magnitude of the response seems to be most greatly affected by a
co-agonist peptide, suggesting that endogenous peptides may play
modulatory roles (Manz et al., 2011). This may provide the T cell
with important environmental cues about the self-peptide reper-
toire on an APC. Or, transient engagement of endogenous ligands
might help to orient the parts of this macromolecular machin-
ery to facilitate assembly of the higher-order units composed of
two agonist pMHC, much in the way that certain peptides bound
to class II MHC can facilitate loading of higher affinity binders
(Rabinowitz et al., 1998).
MULTI-STEP SIGNALING
The discussion to this point has been leading to the idea of multi-
step signaling. What might a multi-step signaling process look
like? Very low ligand densities, including monomers on an APC
or mobile bilayer, can induce a transient co-receptor-dependent
calcium flux for both CD4+ and CD8+ T cells (Irvine et al.,
2002; Purbhoo et al., 2004; Manz et al., 2011). This suggests that
TCR and co-receptor bind to pMHC in relative isolation and
may initiate signaling by transiently relaying information from the
TCR-pMHC interface to some or all of the ITAMs such that they
can be phosphorylated by Lck. Presumably this is where a force
component would be relevant to induce a change in the ITAMs that
alters the positional relationship of the key tyrosines with respect
to the inner leaf of the membrane to make them accessible for
Lck phosphorylation. Based on the geometric constraints imposed
by the canonical docking polarity, the co-receptor-associated Lck
would be in closest proximity to the ITAMs of the CD3γε/CD3δε
signaling module (particularly CD3δε for CD8, Figure 2) and
thus these, and not the ITAMs of the CD3ζζ signaling module,
may be the most likely to initially get phosphorylated at low or
dispersed ligand densities when a T cell first scans the surface
of an APC for agonist pMHCs that can deliver a stop signal.
We find this intriguing for three reasons. First, recent data from
Alarcon and colleagues showed that mutants of the rigid CD3ε
stalk have a dominant negative impact on signaling, which indi-
cates that the CD3ε subunits act cooperatively in TCR signaling
(Martinez-Martin et al., 2009). Second, even though association
of the CD3ε and intracellular domains might mask the critical
tyrosines of the ITAMs from Src kinase phosphorylation under
certain conditions (Xu et al., 2008), the polybasic regions that
mediate such interactions with the acidic inner leaf of the mem-
brane have paradoxically been shown to be important for optimal
TCR signaling (Deford-Watts et al., 2009); perhaps an associa-
tion with the membrane is important to allow these ITAMs to
radiate out toward an approaching co-receptor-associated Lck.
Thirdly,Weiss and colleagues have proposed that two ZAP-70 mol-
ecules bound to paired ITAMs might trans-autophosphorylate to
amplify signaling (Brdicka et al., 2005). Our experiments using the
EPOR intracellular signaling domain as a surrogate for the native
CD3ε intracellular domain show that within a full complex the
two Jak2 molecules associated with the two EPOR domains do
trans-autophosphorylate and signal through the Jak/Stat pathway
(Kuhns et al., 2010). This suggests that the two side-by-side CD3ε
ITAMs could potentially serve as a substrate for signal amplifica-
tion by ZAP-70 and, by extension, all of the ITAMs of the CD3γε
and CD3δε may present a bank of four ITAMs for signal amplifi-
cation that could increase the sensitivity of signaling. Thus, when
a T cell is scanning the surface of an APC for low or dispersed
densities of agonist pMHC, the first step in a multi-step signal-
ing process may involve TCR and co-receptor binding pMHC
to: (i) modify the orientation of the CD3γε and CD3δε ITAMs
such that they are accessible for Lck phosphorylation; (ii) recruit
co-receptor-associated Lck to the ITAMs of the CD3δε/CD3γε
signaling module.
Functionally, the initial signaling events that rely on force may
be transient when agonist pMHC densities are low, either due to a
low ligand density on an APC or as a consequence of the pMHC
being dispersed across the surface of an APC. Yet, they are likely
to deliver the stop signals that ultimately cause a T cell to focus
its full attention toward the pMHC composition on the surface of
an APC. If the T cell detects higher ligand densities on the surface
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of the APC then this could allow for TCR dimerization, which we
have shown is important for T cells to polarize to the point of
antigen contact and form a mature IS that effectively collects the
agonist pMHC into a high local concentration and is a hallmark of
sustained TCR signaling (Kuhns et al., 2010). Higher ligand densi-
ties may more efficiently allow the formation of the higher-order
units shown in Figure 2. This would bring the CD3ζζ homodimers
from two complexes into close proximity, which as Stern and col-
leagues have proposed might cause a release of the critical ITAM
tyrosines from the membrane for phosphorylation by Src kinases
(Aivazian and Stern, 2000). Likewise, a more stable macromole-
cular assembly may facilitate phosphorylation of some or all of
the CD3ζζ ITAMs by co-receptor-associated Lck by holding the
substrates and kinase in close proximity for a greater amount of
time. This could then increase the total number of ITAMs, par-
ticularly for CD3ζζ, which get phosphorylated within a complex
based on the quantity and/or quality of the TCR-pMHC inter-
actions. In such a scenario, dimerization may not be essential to
initiate signaling, but may play a role in modulating or enhanc-
ing sustained signaling as well as delivering information about the
quantity and quality of the pMHC encountered on the surface of
an APC. The formation of these higher-order complexes may also
be important for the sustained signaling that has been reported
upon TCR-CD3 internalization (Yudushkin and Vale, 2010). In
short, returning to the idea of a functional sidedness to the TCR,
we hypothesize that there are multiple steps involved in initiat-
ing and sustaining TCR signaling that control the quantity and
quality of ITAMs that get phosphorylated within a complex upon
ligand engagement. This in turn would impact the outcome of lig-
and engagement with regards to T cell responses such as cytokine
secretion or proliferation.
CLOSING REMARKS
“How does T cell receptor signaling begin?” We have approached
this Research Topic as a forum to reflect on what we know, or
think we know, about TCR signaling and to speculate about what
it might mean. The system is complicated, and there is much we
still do not know. Nevertheless, it is clear that engagement of ago-
nist pMHC by TCRs and co-receptors are the key initiating events
for TCR signaling. From there, the existing data indicate that the
extent to which signaling is sustained depends upon the assembly
of a complex multi-molecular machine, and that signals emerge
from the sum of these parts.
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